Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00791089 · ClinicalTrials.gov registry record · Phase 4
Effects of Fish Oil on Post Ablation Arrhythmias
A Phase 4 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00791089 is a Phase 4 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 12 participants.
The verdict
NCT00791089, a Phase 4 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
To determine if peri-operative treatment with omega-3 fatty acids is associated with a decrease in the incidence of early recurrences of atrial arrhythmias (within 30 days) and an improvement in probability of long-term maintenance of sinus rhythm after radiofrequency catheter ablation for Atrial Fibrillation.
Interventions
- OTHER placebo
- DRUG LOVAZA Omega 3-acid ethyl esters
- DRUG LOVAZA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00791089
The ClinicalTrials.gov registry entry for NCT00791089 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00791089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00791089 about?
NCT00791089 is a clinical study titled "Effects of Fish Oil on Post Ablation Arrhythmias". To determine if peri-operative treatment with omega-3 fatty acids is associated with a decrease in the incidence of early recurrences of atrial arrhythmias (within 30 days) and an improvement in probability of long-term maintenance of sinus rhythm after radiofrequency catheter ablation for Atrial Fi...
What is the current status of trial NCT00791089?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2008-11. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00791089?
The interventions under investigation include: placebo (OTHER), LOVAZA Omega 3-acid ethyl esters (DRUG), LOVAZA (DRUG).
Who is sponsoring clinical trial NCT00791089?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.